In the article cited above, the nomenclature for a novel long noncoding RNA (lncRHL, regulator of hyperlipidemia) was similar to that used for a novel long noncoding RNA in the 2021 Cell Proliferation article below (lnc-RHL, regulator of hepatic lineages). Prabhakar B, Lee S, Bochanis A, He W, Manautou JE, Rasmussen TP. lnc-RHL, a novel long non-coding RNA required for the differentiation of hepatocytes from human bipotent progenitor cells. Cell Prolif 2021;54:e12978. https://doi.org/10.1111/cpr.12978 To prevent possible misattribution of the long noncoding RNAs reported in each paper, the nomenclature for the novel long noncoding RNA regulator of hyperlipidemia has been revised to “lncRHPL.” The online version of the article (https://doi.org/10.2337/db21-1145) has been updated with the revised nomenclature.

中文翻译：

---

勘误表。长链非编码 RNA lncRHL 通过调节 hnRNPU/BMAL1/MTTP 轴调节肝脏 VLDL 分泌。糖尿病 2022；71：1915–1928

在上面引用的文章中，一种新型长链非编码 RNA（lncRHL，高脂血症调节剂）的命名法与下文 2021 年细胞增殖文章中用于一种新型长链非编码 RNA 的命名法（lnc-RHL，肝谱系调节剂）相似。Prabhakar B、Lee S、Bochanis A、He W、Manautou JE、Rasmussen TP。lnc-RHL，一种新型长链非编码 RNA，是从人双能祖细胞分化为肝细胞所必需的。细胞增殖 2021；54：e12978。https://doi.org/10.1111/cpr.12978 为防止每篇论文中报道的长链非编码 RNA 可能出现错误归因，新型高脂血症长链非编码 RNA 调节剂的命名已修改为“lncRHPL”。文章的在线版本 (https://doi.org/10.2337/db21-1145) 已更新为修订后的命名法。